The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $766,886.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on Sep 30, 2023. The 2-year grant supports research on the importance of NKG2D signaling-induced IL-24 secretion by tumor-specific CD8+ T cells. Through this biomedical research project, KUMCRI aims to investigate medical solutions that could transform health care for Service...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $1,550,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "RBP-J INHIBITION AS A NOVEL LATENCY REVERSAL STRATEGY FOR HIV-1-RELATED KIDNEY DISEASES", aims to support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The funding will enable...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $930,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on March 1, 2024, supports research to investigate the progression of ductal carcinoma in situ (DCIS) to invasive basal-like breast cancer, with a focus on the role of N-RAS. The research aims to advance scientific knowledge and develop innovative therapies in the...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $2,494,712 project grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on August 1, 2024, supports a research project titled "Multisensory Dysfunction Phenotypes as Predictors of Cognitive Impairment and Trajectory After Traumatic Brain Injury." The objective of this four-year grant is to investigate how multisensory...
This $1,395,000 Project Grant award from the Department of Defense's Defense Health Agency was made to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) on April 1, 2024. The grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research related to military medicine, with a focus on areas such as cancer and neurological disorders. The purpose of this 3-year grant is to develop a short peptide-based...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
This federal Project Grant award, totaling $3,560,880, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the public. The primary awardee, the University of Kansas Medical Center Research Institute, Inc. (KUMCRI), will conduct sophisticated scientific investigations to address various medical...
This $620,000 Project Grant, awarded on June 15, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to elucidate the late effects of radiation in head and neck cancer patients. The research aims to advance scientific knowledge and develop innovative therapies in the field of cancer. As a prime federal grant recipient, KUMCRI has an extensive...
The Defense Health Agency awarded a $4.23 million Project Grant to the University of Kansas Center for Research Inc. under the Military Medical Research and Development federal grant program (CFDA 12.420) to assess eating disorder and comorbidity risk and resilience in a nationally representative sample of recent military enlistees from April 15, 2023 to April 14, 2027. The University of Kansas will lead the research effort to test the performance of a new eating disorder assessment measure in...
This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...